Immersive Virtual Reality Meditation in Voice Therapy
Voice therapy
+ Meditation
+ Virtual Reality
Laryngeal Diseases+5
+ Nervous System Diseases
+ Neurologic Manifestations
Treatment Study
Summary
Study start date: September 3, 2025
Actual date on which the first participant was enrolled.The study is investigating if using guided meditation through immersive virtual reality (IVR) can improve voice therapy sessions. It focuses on 30 participants who will use the TRIPP application with the Meta Quest 2 virtual reality headset. This technology is famous for providing calming or focusing meditation experiences. The goal is to see if starting voice therapy with these meditations can help people learn and remember the therapy techniques better. This research is important because stress and anxiety can make voice therapy less effective, and finding ways to enhance therapy through IVR could help people manage their vocal issues more successfully. In the study, participants will use the virtual reality headset at the beginning of their voice therapy sessions to engage in guided meditation. This approach aims to improve their attention, self-control, and reduce excessive strain on their voices. The study will evaluate how these meditations impact vocal production and therapy engagement. Although specific risks or benefits are not mentioned, the research hopes to show that incorporating meditation in this way can enhance therapy outcomes by helping participants focus better and manage their stress, potentially leading to better voice control and therapy results.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.60 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.3 intervention groups are designated in this study
33.333% chance of being blinded to the placebo group
Treatment Groups
Group I
ExperimentalGroup II
ExperimentalGroup III
ShamStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Mount Sinai Downtown Union Square
New York, United StatesOpen Mount Sinai Downtown Union Square in Google Maps